Wajahat Mirza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wajahat Mirza has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Hadi Mohammad Khan
Department of General Surgery & Surgical Oncology, Shifa International Hospital, Islamabad, Pakistan
18 shared publications - Mehak Ejaz Khan
General Surgery, Shifa International Hospital, Islamabad, Pakistan
16 shared publications - Hania Iqbal
Resident General Surgery, Shifa International Hospital, Islamabad, Pakistan
15 shared publications - Alishbah Khan
Resident General Surgery, Shifa International Hospital, Islamabad, Pakistan
14 shared publications - Muhammad Bilal Moeen-Ud-Din
Department of Surgery, University of Cincinnati, Cincinnati, USA
12 shared publications Hadi Mohammad Khan
9 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Springer Nature in International Journal of Colorectal Disease
Selective lateral pelvic lymph node dissection versus omission after neoadjuvant therapy for rectal adenocarcinoma with clinically suspicious lateral pelvic nodes: a systematic review and meta-analysis
- 18 November 2026
- Published by Springer Nature in International Journal of Colorectal Disease
Open AccessSelective lateral pelvic lymph node dissection versus omission after neoadjuvant therapy for rectal adenocarcinoma with clinically suspicious lateral pelvic nodes: a systematic review and meta-analysis
- 11 November 2026
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 57 (1)
Postoperative Tumor-Informed Circulating Tumor DNA Status for Molecular Residual Disease Detection After Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
- 11 November 2026
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 57 (1)
Postoperative Tumor-Informed Circulating Tumor DNA Status for Molecular Residual Disease Detection After Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
- Open Access
- 24 October 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1) , 294
Timing of diverting ileostomy closure after low anterior resection for rectal cancer: a GRADE-assessed systematic review and meta-analysis of early and delayed closure
- 24 October 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1) , 294
Open AccessTiming of diverting ileostomy closure after low anterior resection for rectal cancer: a GRADE-assessed systematic review and meta-analysis of early and delayed closure
- Open Access
- 21 August 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 412 (1)
Comparative outcomes of robotic and laparoscopic right colectomy with intracorporeal anastomosis for curative-intent right-sided colonic neoplasia: a GRADE-assessed systematic review and meta-analysis
- 21 August 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 412 (1)
Open AccessComparative outcomes of robotic and laparoscopic right colectomy with intracorporeal anastomosis for curative-intent right-sided colonic neoplasia: a GRADE-assessed systematic review and meta-analysis
- Open Access
- 20 August 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 111
Agreement of endoscopic ultrasound–guided portal pressure gradient with hepatic venous pressure gradient for portal hypertension severity classification: a systematic review and meta-analysis
Background: The severity of portal hypertension (PH) is central to risk stratification in chronic liver disease, yet transjugular HVPG testing is resource-intensive. EUS-guided portal pressure gradient (EUS-PPG) has emerged as an endoscopic alternative, but comparative agreement evidence has not been synthesized for severity classification. Methods: We performed a systematic review and meta-analysis registered in PROSPERO [CRD420261325781]. MEDLINE (PubMed), Embase, Web of Science, Scopus, and Cochrane CENTRAL were searched from inception with citation searching. We identified 274 records, removed 104 duplicates, screened 170 titles/abstracts, assessed 20 full texts, and included 4 prospective, non-randomized paired comparative studies. Random-effects models were used. The primary outcome was quantitative agreement, assessed using correlation coefficients, intraclass correlation, and Bland–Altman metrics. Secondary outcomes included technical success and procedure-related adverse events. Risk of bias was assessed using ROBINS-I, and certainty of evidence was rated using GRADE. Results: Four prospective, non-randomized comparative studies (73 enrolled participants; 69 paired measurements available for analysis) met the inclusion criteria. EUS-PPG showed a high pooled correlation with HVPG ( r = 0.82, 95% CI: 0.72–0.89; p < 0.00001; I² = 0%), with intraclass correlation coefficients ranging from 0.86 to 0.97 and minimal bias on Bland–Altman analysis. The classification accuracy for clinically significant portal hypertension (CSPH) was 100% in two studies. Technical success rates were equivalent (RR 1.00, 95% CI 0.93–1.07), and no significant safety differences were observed (RR 1.23, 95% CI 0.34–4.45). Subgroup analysis by etiology (cirrhosis vs. mixed/non-cirrhotic) showed no difference in agreement. The certainty of evidence was rated very low due to the study design and imprecision. Conclusions: EUS-PPG strongly correlates with transjugular HVPG/TJ-PPG and appears to be as feasible and safe as the latter, according to limited comparative data. Until larger outcome-driven studies validate the threshold-based classification, EUS-PPG should be viewed as a complementary hemodynamic tool to inform selected clinical decisions rather than a universal replacement. Trial registration: [ID: CRD420261325781].
- 20 August 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 111
Open AccessAgreement of endoscopic ultrasound–guided portal pressure gradient with hepatic venous pressure gradient for portal hypertension severity classification: a systematic review and meta-analysis
Background: The severity of portal hypertension (PH) is central to risk stratification in chronic liver disease, yet transjugular HVPG testing is resource-intensive. EUS-guided portal pressure gradient (EUS-PPG) has emerged as an endoscopic alternative, but comparative agreement evidence has not been synthesized for severity classification. Methods: We performed a systematic review and meta-analysis registered in PROSPERO [CRD420261325781]. MEDLINE (PubMed), Embase, Web of Science, Scopus, and Cochrane CENTRAL were searched from inception with citation searching. We identified 274 records, removed 104 duplicates, screened 170 titles/abstracts, assessed 20 full texts, and included 4 prospective, non-randomized paired comparative studies. Random-effects models were used. The primary outcome was quantitative agreement, assessed using correlation coefficients, intraclass correlation, and Bland–Altman metrics. Secondary outcomes included technical success and procedure-related adverse events. Risk of bias was assessed using ROBINS-I, and certainty of evidence was rated using GRADE. Results: Four prospective, non-randomized comparative studies (73 enrolled participants; 69 paired measurements available for analysis) met the inclusion criteria. EUS-PPG showed a high pooled correlation with HVPG ( r = 0.82, 95% CI: 0.72–0.89; p < 0.00001; I² = 0%), with intraclass correlation coefficients ranging from 0.86 to 0.97 and minimal bias on Bland–Altman analysis. The classification accuracy for clinically significant portal hypertension (CSPH) was 100% in two studies. Technical success rates were equivalent (RR 1.00, 95% CI 0.93–1.07), and no significant safety differences were observed (RR 1.23, 95% CI 0.34–4.45). Subgroup analysis by etiology (cirrhosis vs. mixed/non-cirrhotic) showed no difference in agreement. The certainty of evidence was rated very low due to the study design and imprecision. Conclusions: EUS-PPG strongly correlates with transjugular HVPG/TJ-PPG and appears to be as feasible and safe as the latter, according to limited comparative data. Until larger outcome-driven studies validate the threshold-based classification, EUS-PPG should be viewed as a complementary hemodynamic tool to inform selected clinical decisions rather than a universal replacement. Trial registration: [ID: CRD420261325781].
- Open Access
- 10 August 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
Ghost (virtual) ileostomy compared with protective ileostomy after low anterior resection for rectal cancer: A GRADE-assessed systematic review and meta-analysis
- 10 August 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 411 (1)
Open AccessGhost (virtual) ileostomy compared with protective ileostomy after low anterior resection for rectal cancer: A GRADE-assessed systematic review and meta-analysis